BioCentury
ARTICLE | Company News

Intercell, Sanofi-Aventis S.A. deal

September 6, 2004 7:00 AM UTC

The companies extended a February protein-based bacterial vaccines development deal between Intercell and Aventis (see BioCentury, Feb. 23). As extended, Intercell will further develop antigens it ide...